Cancer patient access to unapproved treatments : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, February 29, 1996.
|Corporate Author:||United States.|
Washington : U.S. G.P.O. : 1996.
> Food and Drug Administration.
Clinical trials > United States.
Antineoplastic agents > United States.
Therapeutics, Experimental > United States.
Antineoplaston treatment > United States.
Cancer > Patients > United States.
Cancer > Treatment > United States.
iii, 71 p. ;
|Locate a Print Version:||
Find in a library